 |
Carisma Therapeutics
Last updated: April 15, 2024
Saar Gill, Co-Founder
USA | Funding: $151.9M (+)
Website: http://carismatx.com/
CARMA TherapeuticsSM is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
Website: http://carismatx.com/
CARMA TherapeuticsSM is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
